Predicting surgical outcomes of acute diffuse peritonitis: Updated risk models based on real-world clinical data

被引:1
作者
Sato, Naoya [1 ]
Hirakawa, Shinya [2 ,3 ]
Marubashi, Shigeru [1 ]
Tachimori, Hisateru [2 ,3 ]
Oshikiri, Taro [4 ]
Miyata, Hiroaki [3 ,5 ]
Kakeji, Yoshihiro [4 ]
Kitagawa, Yuko [6 ]
机构
[1] Fukushima Med Univ, Dept Hepatobiliary Pancreat & Transplant Surg, Hikarigaoka 1, Fukushima, Fukushima, Japan
[2] Keio Univ, Sch Med, Endowed Course Hlth Syst Innovat, Tokyo, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Healthcare Qual Assessment, Tokyo, Japan
[4] Japanese Soc Gastroenterol Surg, Database Comm, Tokyo, Japan
[5] Keio Univ, Sch Med, Dept Hlth Policy & Management, Tokyo, Japan
[6] Japanese Soc Gastroenterol Surg, Tokyo, Japan
来源
ANNALS OF GASTROENTEROLOGICAL SURGERY | 2024年 / 8卷 / 04期
关键词
acute diffuse peritonitis; national clinical database; prediction; risk model; CLAVIEN-DINDO CLASSIFICATION; GASTRIC-CANCER; POSTOPERATIVE COMPLICATIONS; CURATIVE GASTRECTOMY; SURVIVAL; IMPACT; MORBIDITY; RESECTION; SURGERY; LEAKAGE;
D O I
10.1002/ags3.12800
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: The existing predictive risk models for the surgical outcome of acute diffused peritonitis (ADP) need renovation by adding relevant variables such as ADP's definition or causative etiology to pursue outstanding data collection reflecting the real world. We aimed to revise the risk models predicting mortality and morbidities of ADP using the latest Japanese Nationwide Clinical Database (NCD) variable set. Methods: Clinical dataset of ADP patients who underwent surgery, and registered in the NCD between 2016 and 2019, were used to develop a risk model for surgical outcomes. The primary outcome was perioperative mortality. Results: After data cleanup, 45 379 surgical cases for ADP were derived for analysis. The perioperative and 30-day mortality were 10.6% and 7.2%, respectively. The prediction models have been created for the mortality and 10 morbidities associated with the mortality. The top five relevant predictors for perioperative mortality were age >80, advanced cancer with multiple metastases, platelet count of <50 000/mL, serum albumin of <2.0 g/dL, and unknown ADP site. The C-indices of perioperative and 30-day mortality were 0.859 and 0.857, respectively. The predicted value calculated with the risk models for mortality was highly fitted with the actual probability from the lower to the higher risk groups. Conclusions: Risk models for postoperative mortality and morbidities with good predictive performance and reliability were revised and validated using the recent real-world clinical dataset. These models help to predict ADP surgical outcomes accurately and are available for clinical settings.
引用
收藏
页码:711 / 727
页数:17
相关论文
共 50 条
  • [21] Outcomes and patterns of treatment in chronic myeloid leukemia, a global perspective based on a real-world data global network
    Sanz, A.
    Ayala, R.
    Hernandez, G.
    Lopez, N.
    Gil-Alos, D.
    Gil, R.
    Colmenares, R.
    Carreno-Tarragona, G.
    Sanchez-Pina, J.
    Alonso, R. A.
    Garcia-Barrio, N.
    Perez-Rey, D.
    Meloni, L.
    Calbacho, M.
    Cruz-Rojo, J.
    Pedrera-Jimenez, M.
    Serrano-Balazote, P.
    de la Cruz, J.
    Martinez-Lopez, J.
    [J]. BLOOD CANCER JOURNAL, 2022, 12 (06)
  • [22] Evaluation of dynamic recurrence risk for locally advanced gastric cancer in the clinical setting of adjuvant chemotherapy: a real-world study with IPTW-based conditional recurrence analysis
    Wu, Dong
    Lu, Jun
    Xue, Zhen
    Zhong, Qing
    Xu, Bin-bin
    Zheng, Hua-Long
    Lin, Guo-sheng
    Shen, Li-li
    Lin, Jia
    Huang, Jiao-bao
    Hakobyan, Davit
    Li, Ping
    Wang, Jia-Bin
    Lin, Jian-Xian
    Chen, Qi-Yue
    Cao, Long-Long
    Xie, Jian-Wei
    Huang, Chang-Ming
    Zheng, Chao-Hui
    [J]. BMC CANCER, 2023, 23 (01)
  • [23] Analysis of Real-world Data on Postremission Therapy for Acute Myeloid Leukemia With Intermediate Risk Cytogenetics in First Complete Remission
    Vydra, Jan
    Salek, Cyril
    Schwarz, Jiri
    Zak, Pavel
    Novak, Jan
    Petecukova, Veronika
    Pecherkova, Pavla
    Mayer, Jiri
    Cetkovsky, Petr
    Racil, Zdenek
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (02) : 106 - 113
  • [24] Analysis of risk factors for immune checkpoint inhibitor-associated liver injury: a retrospective analysis based on clinical study and real-world data
    Wang, Bitao
    Zhuang, Shaowei
    Lin, Shengnan
    Lin, Jierong
    Zeng, Wanxian
    Du, Bin
    Yang, Jing
    [J]. HEPATOLOGY INTERNATIONAL, 2025,
  • [25] Fracture Risk Assessment With FRAX Using Real-World Data in a Population-Based Cohort From Israel
    Goldshtein, Inbal
    Gerber, Yariv
    Ish-shalom, Sophia
    Leshno, Moshe
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2018, 187 (01) : 94 - 102
  • [26] Clinical significance of site-specific metastases in pancreatic cancer: a study based on both clinical trial and real-world data
    Wu, Lixia
    Zhu, Lina
    Xu, Kequn
    Zhou, Siyuan
    Zhou, Yang
    Zhang, Tiening
    Hang, Junjie
    Zee, Benny Chung-Ying
    [J]. JOURNAL OF CANCER, 2021, 12 (06): : 1715 - 1721
  • [27] Real-World Clinical Outcomes Two Years After Transition to Psychosis in Individuals at Clinical High Risk: Electronic Health Record Cohort Study
    Fusar-Poli, Paolo
    De Micheli, Andrea
    Patel, Rashmi
    Signorini, Lorenzo
    Miah, Syed
    Spencer, Thomas
    McGuire, Philip
    [J]. SCHIZOPHRENIA BULLETIN, 2020, 46 (05) : 1114 - 1125
  • [28] A Global Vascular Guidelines-Based Bypass-Preferred Population and Their Surgical Risk in CLTI Patients Treated With Endovascular Therapy in a Real-World Practice
    Okamoto, Shin
    Lida, Osamu
    Takahara, Mitsuyoshi
    Hata, Yosuke
    Asai, Mitsutoshi
    Masuda, Masaharu
    Ishihara, Takayuki
    Nanto, Kiyonori
    Kanda, Takashi
    Tsujimura, Takuya
    Okuno, Syota
    Matsuda, Yasuhiro
    Mano, Toshiaki
    [J]. JOURNAL OF ENDOVASCULAR THERAPY, 2020, 27 (04) : 608 - 613
  • [29] Contemporary Real-World Outcomes of Surgical Aortic Valve Replacement in 141,905 Low-Risk, Intermediate-Risk, and High-Risk Patients
    Thourani, Vinod H.
    Suri, Rakesh M.
    Gunter, Rebecca L.
    Sheng, Shubin
    O'Brien, Sean M.
    Ailawadi, Gorav
    Szeto, Wilson Y.
    Dewey, Todd M.
    Guyton, Robert A.
    Bavaria, Joseph E.
    Babaliaros, Vasilis
    Gammie, James S.
    Svensson, Lars
    Williams, Mathew
    Badhwar, Vinay
    Mack, Michael J.
    [J]. ANNALS OF THORACIC SURGERY, 2015, 99 (01) : 55 - 61
  • [30] Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum-Based Chemotherapy Failure Setting
    Soon, Yu Yang
    Furnback, Wesley
    Kim, Jin
    Chuang, Po-Ya
    Chavez, Gordon
    Proescholdt, Christina
    Koh, Cloe Ying Chee
    [J]. JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (11):